Jacobs Levy Equity Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $123M | Buy |
234,267
+233,520
| +31,261% | +$123M | 0.48% | 50 |
|
|
2025
Q1 | $474K | Sell |
747
-100
| -12% | -$63.4K | ﹤0.01% | 923 |
|
|
2024
Q4 | $603K | Sell |
847
-22,744
| -96% | -$16.2M | ﹤0.01% | 790 |
|
|
2024
Q3 | $24.8M | Buy |
23,591
+10,213
| +76% | +$10.7M | 0.1% | 200 |
|
|
2024
Q2 | $14.1M | Buy |
13,378
+13,016
| +3,596% | +$13.7M | 0.06% | 284 |
|
|
2024
Q1 | $348K | Buy |
362
+6
| +2% | +$5.78K | ﹤0.01% | 847 |
|
|
2023
Q4 | $313K | Buy |
+356
| New | +$313K | ﹤0.01% | 884 |
|
|
2022
Q1 | – | Sell |
-350
| Closed | -$221K | – | 1074 |
|
|
2021
Q4 | $221K | Buy |
+350
| New | +$221K | ﹤0.01% | 930 |
|
|
2018
Q2 | – | Sell |
-1,178
| Closed | -$406K | – | 1084 |
|
|
2018
Q1 | $406K | Buy |
+1,178
| New | +$406K | 0.01% | 810 |
|
|
2016
Q3 | – | Sell |
-30,328
| Closed | -$10.6M | – | 1106 |
|
|
2016
Q2 | $10.6M | Buy |
30,328
+29,753
| +5,174% | +$10.4M | 0.22% | 140 |
|
|
2016
Q1 | $207K | Buy |
+575
| New | +$207K | ﹤0.01% | 963 |
|